171 related articles for article (PubMed ID: 11955027)
1. Severe hepatotoxicity associated with the dietary supplement LipoKinetix.
Favreau JT; Ryu ML; Braunstein G; Orshansky G; Park SS; Coody GL; Love LA; Fong TL
Ann Intern Med; 2002 Apr; 136(8):590-5. PubMed ID: 11955027
[TBL] [Abstract][Full Text] [Related]
2. Summary for patients. Liver failure associated with the dietary supplement LipoKinetix.
Ann Intern Med; 2002 Apr; 136(8):I42. PubMed ID: 11955047
[No Abstract] [Full Text] [Related]
3. Balancing safety of dietary supplements with the free market.
Lewis JD; Strom BL
Ann Intern Med; 2002 Apr; 136(8):616-8. PubMed ID: 11955030
[No Abstract] [Full Text] [Related]
4. 'Dietary supplement' warning.
FDA Consum; 2002; 36(2):4. PubMed ID: 11989472
[No Abstract] [Full Text] [Related]
5. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure.
Estes JD; Stolpman D; Olyaei A; Corless CL; Ham JM; Schwartz JM; Orloff SL
Arch Surg; 2003 Aug; 138(8):852-8. PubMed ID: 12912743
[TBL] [Abstract][Full Text] [Related]
6. Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid.
Sanchez W; Maple JT; Burgart LJ; Kamath PS
Mayo Clin Proc; 2006 Apr; 81(4):541-4. PubMed ID: 16610575
[TBL] [Abstract][Full Text] [Related]
7. Herbal and dietary supplement hepatotoxicity.
Navarro VJ
Semin Liver Dis; 2009 Nov; 29(4):373-82. PubMed ID: 19826971
[TBL] [Abstract][Full Text] [Related]
8. Hepatotoxicity associated with weight loss or sports dietary supplements, including OxyELITE Pro™ - United States, 2013.
Chatham-Stephens K; Taylor E; Chang A; Peterson A; Daniel J; Martin C; Deuster P; Noe R; Kieszak S; Schier J; Klontz K; Lewis L
Drug Test Anal; 2017 Jan; 9(1):68-74. PubMed ID: 27367536
[TBL] [Abstract][Full Text] [Related]
9. The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.
Klontz KC; DeBeck HJ; LeBlanc P; Mogen KM; Wolpert BJ; Sabo JL; Salter M; Seelman SL; Lance SE; Monahan C; Steigman DS; Gensheimer K
Public Health Rep; 2015; 130(5):526-32. PubMed ID: 26327730
[TBL] [Abstract][Full Text] [Related]
10. Dangerous dietary supplements:
Lunsford KE; Bodzin AS; Reino DC; Wang HL; Busuttil RW
World J Gastroenterol; 2016 Dec; 22(45):10071-10076. PubMed ID: 28018115
[TBL] [Abstract][Full Text] [Related]
11. Hepatotoxicity associated with the dietary supplement OxyELITE Pro™ - Hawaii, 2013.
Johnston DI; Chang A; Viray M; Chatham-Stephens K; He H; Taylor E; Wong LL; Schier J; Martin C; Fabricant D; Salter M; Lewis L; Park SY
Drug Test Anal; 2016; 8(3-4):319-27. PubMed ID: 26538199
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity associated with chinese skullcap contained in Move Free Advanced dietary supplement: two case reports and review of the literature.
Linnebur SA; Rapacchietta OC; Vejar M
Pharmacotherapy; 2010 Jul; 30(7):750, 258e-262e. PubMed ID: 20586134
[TBL] [Abstract][Full Text] [Related]
13. Adverse reaction to a dietary supplement in an elderly patient.
Sleeper RB; Kennedy SM
Ann Pharmacother; 2003 Jan; 37(1):83-6. PubMed ID: 12503940
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxicity associated with dietary supplements containing anabolic steroids.
Kafrouni MI; Anders RA; Verma S
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):809-12. PubMed ID: 17509944
[TBL] [Abstract][Full Text] [Related]
15. Renal failure in a soldier taking N.O.-Xplode.
Siano KA
J Am Board Fam Med; 2014; 27(4):565-9. PubMed ID: 25002010
[TBL] [Abstract][Full Text] [Related]
16. Review article: herbal and dietary supplement hepatotoxicity.
Bunchorntavakul C; Reddy KR
Aliment Pharmacol Ther; 2013 Jan; 37(1):3-17. PubMed ID: 23121117
[TBL] [Abstract][Full Text] [Related]
17. Hepatic injury in 12 patients taking the herbal weight loss AIDS Chaso or Onshido.
Adachi M; Saito H; Kobayashi H; Horie Y; Kato S; Yoshioka M; Ishii H
Ann Intern Med; 2003 Sep; 139(6):488-92. PubMed ID: 13679326
[TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity of usnic acid and underlying mechanisms.
Chen S; Ren Z; Guo L
J Environ Sci Health C Toxicol Carcinog; 2024 Jun; ():1-22. PubMed ID: 38904414
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience.
Goldkind L; Laine L
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):213-20. PubMed ID: 16456879
[TBL] [Abstract][Full Text] [Related]
20. Hepatotoxicity due to hydroxycut: a case series.
Fong TL; Klontz KC; Canas-Coto A; Casper SJ; Durazo FA; Davern TJ; Hayashi P; Lee WM; Seeff LB
Am J Gastroenterol; 2010 Jul; 105(7):1561-6. PubMed ID: 20104221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
